Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Axsome Therapeutics INC. (AXSM)

499 + Investors. Track Smart Money conviction in AXSM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +95
Streak
4Q ▲
Buyers last Q
59%

Smart Money Signals — AXSM

Based on 508 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added AXSM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
508 hedge funds hold AXSM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +47% more funds vs a year ago

fund count last 6Q
+162 new funds entered over the past year (+47% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

302 buying212 selling
Last quarter: 302 funds bought or added vs 212 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+69 vs last Q)

new funds entering per quarter
Funds opening a new AXSM position: 50 → 87 → 71 → 140. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

42% of holders stayed for 2+ years

■ 42% conviction (2yr+) ■ 23% medium ■ 35% new
214 out of 508 hedge funds have held AXSM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +50% but shares only +29% — price-driven

Value
+49%
Shares
+29%
Last quarter: the total dollar value of institutional holdings rose +50%, but actual share count only changed +29%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

54 → 50 → 87 → 71 → 140 new funds/Q
New funds entering each quarter: 50 → 87 → 71 → 140. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 52% veterans vs 35% newcomers

■ 52% veterans ■ 12% 1-2yr ■ 35% new
Entry-cohort mix of 534 holders: 280 (52%) are 2+ year veterans, 65 entered 1–2 years ago, and 189 (35%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 50% AUM from top-100 funds

50% from top-100 AUM funds
61 of 503 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in AXSM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — AXSM

In 2026 Q2, 302 hedge funds were net buyers of AXSM (140 opened a new position, 162 added to an existing one), while 212 reduced or exited (167 trimmed, 45 sold completely) — a 59% buyer ratio, indicating a slight buying edge. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 50% of total institutional value in AXSM is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +95 funds (more new holders than closures). Total institutional holders: 508.

Hedge Fund Ownership: AXSM

How many hedge funds hold AXSM — quarterly history vs. share price
Quarterly hedge fund ownership of AXSM vs. share price

Market Analysis: AXSM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AXSM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

25 top-rated funds 12 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
4.7
/ 10
conviction
Hedge Fund Positioning: AXSM
499 + Investors

Track Smart Money conviction in AXSM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 499 413 20.82%
13F Shares 40M 40M 1.0%
Total Value $9.53B $6.40B 49.05%
New Positions 139 71 +68
Increased Positions 159 144 +15
Closed Positions 48 58 -10
Reduced Positions 158 143 +15
Total Calls 18 12 50.0%
Total Puts 13 9 44.44%
PUT/CALL Ratio 0.72 0.75 Neutral

Statistics: AXSM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

499 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AXSM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 AXSM holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Alethea Capital Management, LLC 65.78% 648,756 $158.8M
2 Superstring Capital Management LP 8.33% 53,916 $13.2M
3 Tri Locum Partners LP 6.60% 219,308 $53.7M
4 First Turn Management, LLC 5.72% 218,415 $53.5M
5 Panoramic Capital, LLC 4.63% 44,000 $10.8M
6 PFM Health Sciences, LP 4.61% 219,596 $53.8M
7 Iridian Asset Management LLC/Ct 4.03% 47,924 $11.7M
8 Ally Bridge Group (NY) LLC 3.57% 16,493 $4.0M
9 Occam Crest Management LP 3.52% 29,800 $6.8M
10 Science & Technology Partners, L.P. 3.01% 73,040 $17.9M
11 Ishara Investments LP 2.95% 16,400 $4.0M
12 Integral Health Asset Management, LLC 2.90% 300,000 $73.4M
13 Eagle Health Investments LP 2.64% 65,051 $15.9M
14 Deep Track Capital, LP 2.49% 700,000 $171.3M
15 KVP Capital Advisors, LP 2.16% 12,000 $2.9M
16 1492 Capital Management LLC 2.12% 29,307 $7.2M
17 Goodwin Investment Advisory 2.09% 4,241 $1.0M
18 Sofinnova Investments, Inc. 2.03% 160,429 $39.3M
19 Catalio Capital Management, LP 1.99% 43,182 $10.6M
20 Privium Fund Management B.V. 1.80% 39,944 $9.8M
21 Rhenman & Partners Asset Management AB 1.46% 63,050 $15.4M
22 Nicholas Investment Partners, LP 1.36% 98,974 $24.2M
23 AlphaCentric Advisors LLC 1.35% 6,531 $1.6M
24 Tetragon Partners GP Ltd 1.35% 35,000 $8.6M
25 Seven Fleet Capital Management LP 1.16% 28,826 $7.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Axsome Therapeutics INC. (AXSM)

What does the Smart Money Trend signal show for AXSM?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added AXSM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AXSM?

Slight buying edge — 59% buying: Last quarter: 302 funds bought or added vs 212 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for AXSM holders?

Elite ownership — 50% AUM from top-100 funds: 61 of 503 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in AXSM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held AXSM?

42% of holders stayed for 2+ years: 214 out of 508 hedge funds have held AXSM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →